Northwest Biotherapeutics | NWBO - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agenus USD 19.81M 293.94M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Celldex Therapeutics USD 87.27M 511.09M 2025-12
Eisai JPY 199.9B 16.22B 2025-12
Infinity Pharmaceuticals USD 10.7M 1.54M 2023-06
Merck USD 10.16B 558M 2025-12
Northwest Biotherapeutics USD -108.65M 8.26M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Plus Therapeutics USD 7.11M 1.23M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12